Literature DB >> 22462660

Standard operating procedures for priapism.

Arthur L Burnett1, Ira D Sharlip.   

Abstract

AIM: To provide standard operating procedures for the diagnosis and management of priapism.
METHODS: Review of the literature. MAIN OUTCOME MEASURES: Reduction of priapism and preservation of erectile function.
RESULTS: Priapism is a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation. Priapism requires prompt evaluation and usually requires emergency management. There are two types of priapism: (i) ischemic (veno-occlusive or low flow), which is found in 95% of cases, and (ii) nonischemic (arterial or high flow). Stuttering (intermittent) priapism is a recurrent form of ischemic priapism. To initiate appropriate management, the physician must determine whether the priapism is ischemic or nonischemic. Necessary diagnostic steps are an accurate history, physical examination, and cavernous blood gas analysis and/or color duplex ultrasonography of the corpora cavernosa. Management of ischemic priapism should achieve resolution as promptly as possible. Initial treatment is therapeutic aspiration with or without irrigation of the corpora. If this fails, intracavernous injection of sympathomimetic drugs is the next step. Surgical shunts should be performed if nonsurgical treatment has failed. The initial management of nonischemic priapism should be observation. Selective arterial embolization is recommended for the management of nonischemic priapism in patients who request treatment. The goal of management for a patient with recurrent (stuttering) priapism is prevention of future episodes.
CONCLUSION: Management of priapism has become increasingly successful as scientific understanding of the pathophysiology and molecular biology of priapism improves. The key to further success in the treatment of priapism is basic research of this uncommon but potentially devastating condition.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22462660     DOI: 10.1111/j.1743-6109.2012.02707.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  20 in total

1.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

Review 2.  Embolization Treatment of High-Flow Priapism.

Authors:  Kyung Rae Kim
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

Review 3.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

Review 4.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

Review 5.  Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel.

Authors:  Andrea Salonia; Suks Minhas; Paolo Capogrosso; Kostas Dimitropolous; Giorgio Ivan Russo; Tharu Tharakan; Uros Milenkovic; Andrea Cocci; Luca Boeri; Murat Gül; Carlo Bettocchi; Joana Carvalho; Arif Kalkanlı; Giovanni Corona; Georgios Hatzichristodoulou; Hugh T Jones; Ates Kadioglu; Juan Ignacio Martinez-Salamanca; Vaibhav Modgil; Ege Can Serefoglu; Paolo Verze
Journal:  Int J Impot Res       Date:  2022-08-22       Impact factor: 2.408

Review 6.  [Priapism: Current diagnostics and therapy].

Authors:  B Schwindl; T Bschleipfer; T Klotz
Journal:  Urologe A       Date:  2015-11       Impact factor: 0.639

Review 7.  Malignant Priapism - What Do We Know About It?

Authors:  Dragos Marcu; Lucian Iorga; Dan Mischianu; Nicolae Bacalbasa; Irina Balescu; Ovidiu Bratu
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

8.  Prostate cancer risk after anti-androgen treatment for priapism.

Authors:  Tabitha Goetz; Arthur L Burnett
Journal:  Int Urol Nephrol       Date:  2013-10-18       Impact factor: 2.370

9.  Stuttering priapism in a patient with neurosyphilis.

Authors:  Jong Wook Kim; Ji Yun Chae; Jin Wook Kim; Cheol Yong Yoon; Mi Mi Oh; Je Jong Kim; Du Geon Moon
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

10.  Risk Factors for Surgical Shunting in a Large Cohort With Ischemic Priapism.

Authors:  Hanson Zhao; Kai Dallas; John Masterson; Eric Lo; Justin Houman; Carl Berdahl; Joshua Pevnick; Jennifer T Anger
Journal:  J Sex Med       Date:  2020-11-15       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.